Amit Mohan, MD
Psychiatry · Beachwood, OHNPI 1821219841
Payments from drug & device makers
Across 619 payments — averaging $381.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$141K
- AbbVie$67K
- Otsuka America Pharmaceutical, Inc.$22K
- Johnson & Johnson$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$759
- Sunovion Pharmaceuticals Inc.$690
- plus $3K from 24 others
What the payments were for
- Speaking & faculty fees$212,01490%
- Travel & lodging$12,7725%
- Food & beverage$11,3385%
- Education$650%
- Gifts$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 145 | $140,996 |
| AbbVie(2 entities) | 166 | $67,340 |
| Otsuka America Pharmaceutical, Inc. | 61 | $22,162 |
| Johnson & Johnson | 28 | $1,665 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 32 | $759 |
| Sunovion Pharmaceuticals Inc. | 38 | $690 |
| Lundbeck LLC | 24 | $399 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $341 |
| Jazz Pharmaceuticals Inc. | 18 | $337 |
| Teva Pharmaceuticals USA, Inc. | 17 | $313 |
| Vanda Pharmaceuticals Inc. | 10 | $224 |
| Axsome Therapeutics, Inc. | 5 | $192 |
| Neurocrine Biosciences, Inc. | 6 | $122 |
| Neos Therapeutics, LP | 6 | $108 |
| Ironshore Pharmaceuticals Inc. | 4 | $90 |
| Harmony Biosciences LLC | 2 | $61 |
| Bausch Health US, LLC | 3 | $59 |
| Indivior Inc. | 4 | $55 |
| Corium, LLC | 4 | $46 |
| Merck | 3 | $44 |
| Adlon Therapeutics L.p. | 3 | $36 |
| Tempus AI, Inc | 2 | $32 |
| Tris Pharma Inc | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| Neuronetics, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Validus Pharmaceuticals LLC | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$236,191 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Beachwood
- Boris RoyakBeachwood$62K
- Shishuka MalhotraCanton$15M
- Henry NasrallahCincinnati$3.8M
- Otto DuenoDayton$3.1M
- Diab AlmhanaAvon Lake$2.7M
- Mohamed Abdel AzizWest Chester$2.6M
- Fred RomeoColumbus$2.3M
- Mark WoyshvilleMiddleburg Heights$2.2M
- Amita PatelDayton$2.1M
- Caleb AdlerCincinnati$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.